“…However, vanadium therapy fails in other metabolic complications of STZ-rats that are corrected by the action of insulin, as the daily weight-gain, that can be only partially corrected by therapy with this trace mineral [76], and the increased rate in muscle protein degradation, where vanadium is ineffective [77]. In addition, it is implicated in the inhibition of protein synthesis, amino acid uptake and mitogenesis, but these effects do not necessarily represent a risk, since the inhibition of growth effects of insulin could alleviate macrovascular disease [78], besides, it has been shown to have anti-tumor properties and is being studied as a potential therapeutic agent in this regard [79][80][81][82][83].…”